AbbVie Frees Taxpayers From M&A Capital Loss Limitations

In a significant win for taxpayers, on June 17 the U.S. Tax Court ruled in AbbVie Inc. v. Commissioner that a $1.6 billion break fee paid by AbbVie qualifies as an...